×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Spain Closed System Drug Transfer Device Market

ID: MRFR/MED/47922-HCR
200 Pages
Garvit Vyas
February 2026

Spain Closed System Drug Transfer Device Market Research Report: Size, Share, Trend Analysis By Types (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Spain Closed System Drug Transfer Device Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Spain Closed System Drug Transfer Device Market Summary

As per Market Research Future analysis, the Spain closed system-drug-transfer-device market size was estimated at 33.0 USD Million in 2024. The Spain closed system-drug-transfer-device market is projected to grow from 35.85 USD Million in 2025 to 82.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 8.6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Spain closed system-drug-transfer-device market is poised for growth driven by regulatory support and technological advancements.

  • Regulatory support and compliance are increasingly shaping the market landscape in Spain.
  • Technological advancements are enhancing the efficiency and safety of drug transfer systems.
  • The largest segment in this market is the oncology segment, while the fastest-growing segment is the critical care segment.
  • Key market drivers include the rising demand for safety in healthcare and regulatory framework enhancements.

Market Size & Forecast

2024 Market Size 33.0 (USD Million)
2035 Market Size 82.0 (USD Million)
CAGR (2025 - 2035) 8.63%

Major Players

Baxter International Inc (US), B. Braun Melsungen AG (DE), Cardinal Health Inc (US), Cypress Medical Products LLC (US), ICU Medical Inc (US), Merit Medical Systems Inc (US), Pall Corporation (US), Terumo Corporation (JP)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Spain Closed System Drug Transfer Device Market Trends

The closed system-drug-transfer-device market is currently experiencing notable growth, driven by increasing awareness regarding safety and efficacy in drug handling. Regulatory bodies in Spain are emphasizing the importance of minimizing exposure to hazardous drugs, which has led to a surge in demand for these devices. Healthcare facilities are increasingly adopting closed systems to enhance safety protocols, thereby reducing the risk of contamination and ensuring better protection for healthcare professionals and patients alike. Furthermore, advancements in technology are contributing to the development of more efficient and user-friendly devices, which may further stimulate market expansion. In addition, the closed system-drug-transfer-device market is likely to benefit from ongoing research and development initiatives aimed at improving device functionality and reliability. The Spanish healthcare sector is progressively investing in innovative solutions that align with international safety standards. This trend suggests a promising future for the market, as stakeholders recognize the critical role these devices play in safeguarding health outcomes. As the landscape evolves, collaboration between manufacturers and healthcare providers may enhance the overall effectiveness of drug transfer systems, ultimately leading to improved patient care and operational efficiency.

Regulatory Support and Compliance

The closed system-drug-transfer-device market is witnessing increased regulatory support from Spanish health authorities. This trend indicates a commitment to ensuring safety in drug handling, which may drive adoption rates among healthcare facilities. Compliance with stringent regulations is becoming a priority, prompting organizations to invest in advanced systems that meet these standards.

Technological Advancements

Innovations in technology are shaping the closed system-drug-transfer-device market. Manufacturers are focusing on developing devices that offer enhanced safety features and ease of use. This trend suggests that as technology evolves, the market may see a shift towards more sophisticated solutions that improve efficiency and reduce risks associated with drug transfer.

Growing Awareness of Safety Protocols

There is a rising awareness regarding the importance of safety protocols in healthcare settings. This trend is influencing the closed system-drug-transfer-device market, as healthcare professionals recognize the need to minimize exposure to hazardous substances. Increased training and education on the use of these devices may further support their adoption in various medical environments.

Spain Closed System Drug Transfer Device Market Drivers

Regulatory Framework Enhancements

In Spain, the regulatory landscape surrounding the closed system-drug-transfer-device market is evolving, with authorities implementing stricter guidelines to ensure the safe handling of hazardous drugs. These regulations are designed to protect healthcare workers and patients from potential exposure to toxic substances. The Spanish Agency of Medicines and Medical Devices (AEMPS) has been proactive in establishing standards that manufacturers must adhere to, thereby fostering a more secure environment for drug administration. Compliance with these regulations is expected to drive market growth, as healthcare facilities seek to align with legal requirements. The closed system-drug-transfer-device market is likely to benefit from this regulatory push, as it encourages the adoption of safer drug transfer technologies.

Rising Incidence of Chronic Diseases

The prevalence of chronic diseases in Spain is on the rise, leading to an increased demand for effective drug delivery systems. Conditions such as cancer, diabetes, and autoimmune disorders require the administration of hazardous drugs, which necessitates the use of closed system-drug-transfer devices to ensure safe handling. The growing patient population suffering from these chronic conditions is likely to propel the closed system-drug-transfer-device market forward. According to recent health statistics, the incidence of cancer alone is expected to increase by 15% over the next decade, further emphasizing the need for reliable drug transfer solutions. This trend indicates a robust market potential as healthcare providers seek to enhance patient safety and treatment efficacy.

Focus on Cost-Effectiveness in Healthcare

In the context of Spain's healthcare system, there is a growing emphasis on cost-effectiveness, which is influencing the closed system-drug-transfer-device market. Healthcare facilities are increasingly evaluating the economic impact of their purchasing decisions, seeking solutions that not only ensure safety but also provide value for money. Closed system-drug-transfer devices, while initially more expensive, can lead to significant cost savings in the long run by reducing the risk of contamination and associated healthcare costs. This focus on cost-effectiveness is likely to drive the adoption of these devices, as healthcare providers recognize the long-term benefits. The closed system-drug-transfer-device market is expected to thrive as institutions prioritize both safety and economic viability.

Increasing Demand for Safety in Healthcare

The closed system-drug-transfer-device market in Spain is experiencing a notable surge in demand driven by heightened awareness of safety protocols among healthcare professionals. This demand is largely influenced by the need to minimize exposure to hazardous drugs, which has become a priority in hospitals and clinics. As a result, healthcare facilities are increasingly adopting closed system-drug-transfer devices to ensure the safety of both patients and healthcare workers. The market is projected to grow at a CAGR of approximately 8% over the next five years, reflecting the critical importance of safety in drug handling. This trend indicates a shift towards more stringent safety measures, which is likely to bolster the closed system-drug-transfer-device market significantly.

Technological Innovations in Drug Transfer Systems

The closed system-drug-transfer-device market is witnessing a wave of technological innovations that enhance the efficiency and safety of drug transfer processes. In Spain, manufacturers are investing in research and development to create advanced devices that incorporate features such as automated systems and real-time monitoring. These innovations not only improve the accuracy of drug delivery but also reduce the risk of contamination and exposure to hazardous substances. As a result, healthcare providers are increasingly inclined to adopt these cutting-edge solutions, which are expected to drive market growth. The closed system-drug-transfer-device market is projected to expand as these technological advancements become more prevalent in clinical settings.

Market Segment Insights

By Type: Membrane-To-Membrane Systems (Largest) vs. Needleless Systems (Fastest-Growing)

In the Spain closed system-drug-transfer-device market, Membrane-To-Membrane Systems hold a significant share as the largest segment, dominating the landscape of drug transfer technologies. Needleless Systems, while currently smaller in market presence, show promising growth trajectories, reflecting changing demands in the healthcare industry. This distribution highlights a clear preference among healthcare providers for effective and safe drug transfer solutions, ensuring patient safety and minimizing contamination risks. Growth trends within this segment are driven by advancements in technology and increasing awareness of safety protocols in healthcare settings. Membrane-To-Membrane Systems are being adopted extensively due to their proven reliability, while Needleless Systems are emerging rapidly as more facilities seek to eliminate the risks associated with needle use. Regulatory support and innovations are expected to further enhance the attractiveness of both systems, signifying a robust market future.

Membrane-To-Membrane Systems (Dominant) vs. Needleless Systems (Emerging)

Membrane-To-Membrane Systems have established themselves as a dominant force in the Spain closed system-drug-transfer-device market, recognized for their effectiveness in ensuring secure drug transfer processes. Their design allows for streamlined operations, significantly reducing contamination risks associated with traditional methods. On the other hand, Needleless Systems are regarded as an emerging segment, capturing the interest of healthcare institutions aiming for improved safety measures. These systems minimize the risk of needle-stick injuries and are increasingly favored in environments prioritizing patient safety. The drive for innovation and the need for safer drug administration practices suggest a growing adoption of both Membrane-To-Membrane and Needleless Systems, reflecting their respective positions in the market.

By Component: Vial Access Devices (Largest) vs. Syringe Safety Devices (Fastest-Growing)

In the Spain closed system-drug-transfer-device market, the component segment is significantly dominated by Vial Access Devices, which holds the largest market share. Following closely are Syringe Safety Devices, which have been gaining traction due to their enhanced safety features. The market distribution highlights a competitive landscape where Bag/Line Access Devices and Accessories, albeit smaller, play a crucial role in complementing the primary devices. The overall segment reflects a growing trend toward safety and efficiency in drug transfer methods. Growth trends in this segment are primarily fueled by increasing regulatory demands for safety and the rising incidence of needlestick injuries in healthcare settings. Innovations in design and technology are driving the development of safer syringe systems, making them more appealing to healthcare providers. As the market evolves, there is a clear shift towards devices that not only enhance safety but also improve operational efficiency within medical facilities, thus driving further growth for the Syringe Safety Devices category.

Vial Access Devices (Dominant) vs. Bag/Line Access Devices (Emerging)

Vial Access Devices are recognized as the dominant component within the Spain closed system-drug-transfer-device market, owing to their critical role in the secure access of medications stored in vials. They are a preferred choice among healthcare professionals for their reliability and ease of use. In contrast, Bag/Line Access Devices represent an emerging segment, characterized by a growing demand for more versatile and efficient drug transfer solutions. While they currently occupy a smaller market share, advancements in technology and increasing integration in hospital settings position them favorably for future growth, especially as healthcare facilities seek to streamline medication delivery processes and reduce contamination risks.

By Closing Mechanism: Luer Lock Systems (Largest) vs. Click-To Lock System (Fastest-Growing)

In the Spain closed system-drug-transfer-device market, the distribution of market share among the closing mechanisms demonstrates a clear hierarchy of preference. Luer Lock Systems capture the largest share due to their established reliability and compatibility across various applications. Meanwhile, Push To Turn System and Color-To-Color Alignment System, while possessing niche markets, lack the widespread adoption seen with Luer Lock. These characteristics shape the current competitive landscape, with Luer Lock firmly holding the majority. Growth trends within this segment indicate that while Luer Lock Systems remain dominant, Click-To Lock Systems are poised for rapid growth. Factors such as technological advancements, increasing demand for safety features, and the push for user-friendly design are driving this evolution. The emerging interest in Click-To Lock Systems reflects a consumer preference for innovative solutions in drug transfer devices, highlighting a shift in industry focus that may alter market dynamics in the coming years.

Luer Lock Systems (Dominant) vs. Click-To Lock System (Emerging)

Luer Lock Systems are characterized by their secure attachment and versatility, making them the predominant choice for a variety of drug transfer applications. This system allows for a reliable connection between different components, which is essential for maintaining sterility and minimizing the risk of contamination. As a well-established market leader, Luer Lock caters to a wide range of medical applications and continues to evolve with innovative designs that enhance user experience. In contrast, Click-To Lock Systems represent an emerging segment focused on improving usability and safety. With a mechanism that provides audible and tactile feedback, this system is gaining traction within the market. The rising interest in Click-To Lock Systems reflects a shift toward more intuitive designs that prioritize ease of use, particularly for healthcare professionals requiring efficient and reliable drug transfer solutions.

By Technology: Compartmentalize Devices (Largest) vs. Diaphragm-Based Devices (Fastest-Growing)

In the Spain closed system-drug-transfer-device market, Compartmentalize Devices currently hold the largest market share, driven by their efficiency and reliability in enhancing drug safety during transfer. This segment's dominance is attributed to increasing demand for robust transfer solutions that minimize contamination risks, making them the preferred choice among healthcare professionals. On the other hand, Diaphragm-Based Devices are emerging as the fastest-growing segment, benefiting from innovations in design and functionality. The rising trend toward automation in healthcare settings and the demand for devices that offer both safety and precision are key drivers fueling growth in this segment. Increased awareness of safety protocols has also contributed to the rising adoption rates of these devices.

Technology: Compartmentalize Devices (Dominant) vs. Diaphragm-Based Devices (Emerging)

Compartmentalize Devices are characterized by their structured design that allows for safe and efficient drug transfers. This dominance in the Spain closed system-drug-transfer-device market is due in part to their proven track record in minimizing contamination, ensuring regulatory compliance, and bolstering operational efficiency in pharmaceutical settings. Conversely, Diaphragm-Based Devices represent an emerging technology that is gaining traction for their innovative approach to drug transfer. They offer enhanced safety features and can adapt to various drug formulations, appealing to a diverse range of healthcare applications. Their growth is fueled by shifts towards more technologically advanced solutions that emphasize safety and user-friendliness.

By End User: Hospitals & Clinics (Largest) vs. Specialty Centers (Fastest-Growing)

In the Spain closed system-drug-transfer-device market, Hospitals & Clinics hold the largest share among end-user segments, driven by their extensive use of advanced medical technologies and increasing patient volumes. Specialty Centers are becoming increasingly relevant, as they capture a growing share due to their focused care, particularly in areas like oncology and chronic diseases. This balance indicates a diversified approach to healthcare facilities in Spain, with each segment contributing uniquely to the overall market landscape. Growth trends indicate a significant shift toward Specialty Centers, which are adopting closed system drug transfer devices at a faster rate than traditional Hospitals & Clinics. The expanding emphasis on safety protocols and infection control in medical settings fuels this shift, alongside advancements in technology, making these devices more accessible and efficient for various treatments. These trends reflect a changing care paradigm, where specialized facilities are expected to thrive in the coming years.

Hospitals & Clinics (Dominant) vs. Specialty Centers (Emerging)

Hospitals & Clinics represent the dominant segment in the Spain closed system-drug-transfer-device market, characterized by their comprehensive service offerings and high volume of drug administration procedures. They utilize closed systems to ensure safety and efficiency in drug transfer, which is critical in hospital settings. On the other hand, Specialty Centers are emerging as a vital segment, focusing on specific medical areas like oncology, which drives their need for advanced drug transfer solutions. With an emphasis on patient safety and treatment precision, these centers are rapidly adopting closed system solutions, positioning themselves as competitive players in the market. The trend towards specialization in healthcare is clearly beneficial for both segments, but the rapid growth of Specialty Centers cannot be overlooked.

Get more detailed insights about Spain Closed System Drug Transfer Device Market
Request Free Sample

Key Players and Competitive Insights

The closed system-drug-transfer-device market in Spain is characterized by a competitive landscape that is increasingly shaped by innovation, regulatory compliance, and strategic partnerships. Key players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and ICU Medical Inc (US) are actively pursuing strategies that emphasize technological advancements and market expansion. Baxter International Inc (US) focuses on enhancing its product portfolio through continuous innovation, while B. Braun Melsungen AG (DE) emphasizes regional expansion and compliance with stringent European regulations. ICU Medical Inc (US) appears to be leveraging strategic partnerships to enhance its market presence, collectively shaping a competitive environment that is dynamic and responsive to emerging healthcare needs.In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and optimize operational efficiencies. The market structure is moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and solutions, catering to various healthcare settings and patient needs. The collective influence of these key players fosters a competitive atmosphere where innovation and quality are paramount.

In October Baxter International Inc (US) announced the launch of a new closed system-drug-transfer-device designed to enhance safety and efficiency in drug preparation. This strategic move is significant as it aligns with the growing demand for safer drug handling practices in healthcare settings, potentially positioning Baxter as a leader in this niche market. The introduction of this device may also reflect the company's commitment to addressing regulatory requirements and improving patient outcomes.

In September B. Braun Melsungen AG (DE) expanded its manufacturing capabilities in Spain, investing €10 million in a new facility dedicated to producing closed system-drug-transfer-devices. This investment underscores the company's strategy to localize production and enhance supply chain resilience, which is increasingly critical in today's market. By bolstering its manufacturing presence, B. Braun aims to meet the rising demand for its products while ensuring compliance with local regulations.

In August ICU Medical Inc (US) entered into a strategic partnership with a leading Spanish healthcare provider to integrate its closed system-drug-transfer-devices into their hospital systems. This collaboration is likely to enhance ICU Medical's market penetration and provide valuable insights into customer needs, thereby informing future product development. Such partnerships are indicative of a broader trend where companies seek to align closely with healthcare providers to ensure their products meet real-world demands.

As of November the competitive trends in the closed system-drug-transfer-device market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product offerings. Strategic alliances are becoming more prevalent, allowing companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, product reliability, and supply chain efficiency. This shift suggests that companies that prioritize innovation and sustainability will be better positioned to thrive in the future.

Key Companies in the Spain Closed System Drug Transfer Device Market include

Industry Developments

In recent months, significant developments have emerged in the Spain Closed System Drug Transfer Device Market, notably driven by advances in healthcare protocols emphasizing safety and efficiency. Becton Dickinson and BD Medical have been reported increasing their investments in Research and Development to enhance the efficacy of drug transfer systems utilized in oncology and hazardous drug administration.

Smiths Medical and Terumo Corporation continue to expand their product ranges, aligning with the heightened demand for effective drug delivery systems amid Spain's health sector reforms. In September 2023, Baxter International announced a strategic partnership with West Pharmaceutical Services aimed at improving product accessibility and innovation in Spain.

Moreover, the market has witnessed notable growth, with several companies including Fresenius Kabi and Cardinal Health reporting increased valuations influenced by growing healthcare expenditures. The European Medicines Agency's regulatory policies have also intensified scrutiny on medical devices, pushing companies to adhere to strict compliance standards.

In the last couple of years, major companies like C. R. Bard have collaborated on technological advancements, reflecting an industry dedicated to improving patient safety and care efficiency. Overall, the Spain Closed System Drug Transfer Device Market is evolving rapidly, underscoring increased significance in healthcare settings.

Future Outlook

Spain Closed System Drug Transfer Device Market Future Outlook

The Closed System Drug Transfer Device Market in Spain is projected to grow at 8.63% CAGR from 2025 to 2035, driven by increasing safety regulations and technological advancements.

New opportunities lie in:

  • Development of integrated software solutions for device tracking and compliance.
  • Expansion into home healthcare markets with portable drug transfer devices.
  • Partnerships with hospitals for customized training programs on device usage.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

Spain Closed System Drug Transfer Device Market Type Outlook

  • Membrane-To-Membrane Systems
  • Needleless Systems

Spain Closed System Drug Transfer Device Market End User Outlook

  • Hospitals & clinics
  • Specialty centers
  • Others

Spain Closed System Drug Transfer Device Market Component Outlook

  • Vial Access Devices
  • Syringe Safety Devices
  • Bag/Line Access Devices
  • Accessories

Spain Closed System Drug Transfer Device Market Technology Outlook

  • Compartmentalize Devices
  • Diaphragm-Based Devices
  • Air Filtration Devices

Spain Closed System Drug Transfer Device Market Closing Mechanism Outlook

  • Push To Turn System
  • Color-To-Color Alignment System
  • Luer Lock Systems
  • Click-To Lock System

Report Scope

MARKET SIZE 2024 33.0(USD Million)
MARKET SIZE 2025 35.85(USD Million)
MARKET SIZE 2035 82.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 8.63% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Baxter International Inc (US), B. Braun Melsungen AG (DE), Cardinal Health Inc (US), Cypress Medical Products LLC (US), ICU Medical Inc (US), Merit Medical Systems Inc (US), Pall Corporation (US), Terumo Corporation (JP)
Segments Covered Type, Component, Closing Mechanism, Technology, End User
Key Market Opportunities Growing demand for safety and efficiency in drug handling drives innovation in closed system-drug-transfer-device market.
Key Market Dynamics Rising regulatory scrutiny drives innovation and adoption of closed system-drug-transfer-devices in Spain's healthcare sector.
Countries Covered Spain
Leave a Comment

FAQs

What is the expected market size of the Spain Closed System Drug Transfer Device Market in 2024?

The Spain Closed System Drug Transfer Device Market is expected to be valued at 30.0 USD Million in 2024.

What will the market size be by 2035?

By 2035, the market size is projected to reach 185.0 USD Million.

What is the expected compound annual growth rate (CAGR) for the market from 2025 to 2035?

The expected CAGR for the Spain Closed System Drug Transfer Device Market from 2025 to 2035 is 17.984%.

Which segments hold the largest market shares within the Spain Closed System Drug Transfer Device Market?

The Membrane to Membrane segment is expected to be valued at 12.0 USD Million in 2024 and reach 75.0 USD Million by 2035, while the Needleless System segment will grow from 18.0 USD Million in 2024 to 110.0 USD Million in 2035.

Who are the key players operating in the Spain Closed System Drug Transfer Device Market?

Major players in the market include Becton Dickinson, BD Medical, Smiths Medical, Terumo Corporation, and Baxter International.

What key trends are currently shaping the Spain Closed System Drug Transfer Device Market?

Emerging trends include innovation in drug delivery systems and increasing focus on safety and efficiency in drug transfer.

What challenges does the Spain Closed System Drug Transfer Device Market currently face?

Challenges include regulatory hurdles and the need for significant investment in new technologies.

What applications are driving growth in the Closed System Drug Transfer Device Market?

Applications in oncology and hazardous drug handling are significant growth drivers for the market.

How does regional growth vary within the Spain Closed System Drug Transfer Device Market?

Regional growth is expected to vary, with increased demand in urban healthcare facilities compared to rural areas.

What is the projected impact of global economic factors on the Spain Closed System Drug Transfer Device Market?

Global economic factors are expected to enhance demand for safety-oriented devices, thus positively impacting the market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓